Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
about
Chemotherapy for hepatocellular carcinoma: The present and the future.Deguelin inhibits epithelial-to-mesenchymal transition and metastasis of human non-small cell lung cancer cells by regulating NIMA-related kinase 2.Importance of protein flexibility on molecular recognition: modeling binding mechanisms of aminopyrazine inhibitors to Nek2.NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer.Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic review
P2860
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
@en
type
label
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
@en
prefLabel
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
@en
P2093
P2860
P356
P1476
Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression
@en
P2093
Chau-Ting Yeh
Chia-Jung Liao
Chung-Ying Tsai
Hsiang-Cheng Chi
Kang-Yun Lee
Kwang-Huei Lin
Po-Hao Feng
Sheng-Ming Wu
Syuan-Ling Lin
Wan-Li Cheng
P2860
P304
P356
10.1002/IJC.30559
P577
2017-01-19T00:00:00Z